Abstract
Each of the DENV serotypes can cause the full spectrum of dengue illness. Epidemiological studies have implicated preexisting heterotypic DENV antibody as a risk factor for more severe disease upon secondary DENV infection. For these reasons, a successful DENV vaccine must protect against all four DENV serotypes. Live attenuated DENV vaccine candidates are the furthest along in development and clinical evaluation. Two live attenuated tetravalent vaccine candidates are in Phase 2 clinical trials in DENV endemic regions. Numerous other vaccine candidates including inactivated whole virus, recombinant subunit protein, DNA and virus-vectored vaccines are also under development. Those DENV vaccine candidates that have been evaluated in preclinical animal models or in clinical trials will be discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Allison SL, Stadler K, Mandl CW, Kunz C, Heinz FX (1995) J Virol 69:5816–5820
Apt D, Raviprakash K, Brinkman A, Semyonov A, Yang S, Skinner C, Diehl L, Lyons R, Porter K, Punnonen J (2006) Vaccine 24:335–344
Bancroft WH, Scott RM, Eckels KH, Hoke CH Jr, Simms TE, Jesrani KD, Summers PL, Dubois DR, Tsoulos D, Russell PK (1984) J Infect Dis 149:1005–1010
Bancroft WH, Top FH Jr, Eckels KH, Anderson JH Jr, McCown JM, Russell PK (1981) Infect Immun 31:698–703
Bhamarapravati N, Sutee Y (2000) Vaccine 18:44–47
Bhamarapravati N, Yoksan S (1989) Lancet 1:1077
Bhamarapravati N, Yoksan S (1997) Live attenuated tetravalent dengue vaccine. In: Gubler DJ, Kuno G (eds) Dengue and dengue hemorrhagic fever. CABI Publishing, New York, pp 367–377
Bhamarapravati N, Yoksan S, Chayaniyayothin T, Angsubphakorn S, Bunyaratvej A (1987) Bull WHO 65:189–195
Bielefeldt-Ohmann H, Beasley DW, Fitzpatrick DR, Aaskov JG (1997) J Gen Virol 78:2723–2733
Bisht H, Chugh DA, Raje M, Swaminathan SS, Khanna N (2002) J Biotechnol 99:97–110
Blanc G, Caminopetros J (1929) Bull Acad Med 102:37–40
Blaney JE Jr, Hanson CT, Firestone CY, Hanley KA, Murphy BR, Whitehead SS (2004a) Am J Trop Med Hyg 71:811–821
Blaney JE Jr, Hanson CT, Hanley KA, Murphy BR, Whitehead SS (2004b) BMC Infect Dis 4:39
Blaney JE Jr, Matro JM, Murphy BR, Whitehead SS (2005) J Virol 79:5516–5528
Blaney JE Jr, Sathe NS, Goddard L, Hanson CT, Romero TA, Hanley KA, Murphy BR, Whitehead SS (2008) Vaccine 26:817–828
Bray M, Lai CJ (1991) Proc Natl Acad Sci USA 88:10342–10346
Bray M, Zhao BT, Markoff L, Eckels KH, Chanock RM, Lai CJ (1989) J Virol 63:2853–2856
Butrapet S, Huang CY, Pierro DJ, Bhamarapravati N, Gubler DJ, Kinney RM (2000) J Virol 74:3011–3019
Catanzaro AT, Koup RA, Roederer M, Bailer RT, Enama ME, Moodie Z, Gu L, Martin JE, Novik L, Chakrabarti BK, Butman BT, Gall JG, King CR, Andrews CA, Sheets R, Gomez PL, Mascola JR, Nabel GJ, Graham BS (2006) J Infect Dis 194:1638–1649
Chen L, Ewing D, Subramanian H, Block K, Rayner J, Alterson KD, Sedegah M, Hayes C, Porter K, Raviprakash K (2007) J Virol 81:11634–11639
Costa SM, Azevedo AS, Paes MV, Sarges FS, Freire MS, Alves AM (2007) Virology 358:413–423
Delenda C, Frenkiel MP, Deubel V (1994a) Arch Virol 139:197–207
Delenda C, Staropoli I, Frenkiel MP, Cabanie L, Deubel V (1994b) J Gen Virol 75:1569–1578
Deubel V, Bordier M, Megret F, Gentry MK, Schlesinger JJ, Girard M (1991) Virology 180:442–447
Deubel V, Kinney RM, Esposito JJ, Cropp CB, Vorndam AV, Monath TP, Trent DW (1988) J Gen Virol 69:1921–1929
Durbin AP, Karron RA, Sun W, Vaughn DW, Reynolds MJ, Perreault JR, Thumar B, Men R, Lai CJ, Elkins WR, Chanock RM, Murphy BR, Whitehead SS (2001) Am J Trop Med Hyg 65:405–413
Durbin AP, McArthur J, Marron JA, Blaney JE Jr, Thumar B, Wanionek K, Murphy BR, Whitehead SS (2006a) Hum Vaccin 2:167–173
Durbin AP, McArthur JH, Marron JA, Blaney JE, Thumar B, Wanionek K, Murphy BR, Whitehead SS (2006b) Hum Vaccin 2:255–260
Durbin AP, Whitehead SS, McArthur J, Perreault JR, Blaney JE Jr, Thumar B, Murphy BR, Karron RA (2005) J Infect Dis 191:710–718
Eckels KH, Dubois DR, Summers PL, Schlesinger JJ, Shelly M, Cohen S, Zhang YM, Lai CJ, Kurane I, Rothman A, Hasty S, Howard B (1994) Am J Trop Med Hyg 50:472–478
Eckels KH, Scott RM, Bancroft WH, Brown J, Dubois DR, Summers PL, Russell PK, Halstead SB (1984) Am J Trop Med Hyg 33:684–689
Edelman R, Tacket CO, Wasserman SS, Vaughn DW, Eckels KH, Dubois DR, Summers PL, Hoke CH (1994) J Infect Dis 170:1448–1455
Edelman R, Wasserman SS, Bodison SA, Putnak RJ, Eckels KH, Tang D, Kanesa-Thasan N, Vaughn DW, Innis BL, Sun W (2003) Am J Trop Med Hyg 69:48–60
Feighny R, Burrous J, Putnak R (1994) Am J Trop Med Hyg 50:322–328
Fonseca BA, Pincus S, Shope RE, Paoletti E, Mason PW (1994) Vaccine 12:279–285
Fujita N, Oda K, Yasui Y, Hotta S (1969) Kobe J Med Sci 15:163–180
Guirakhoo F, Arroyo J, Pugachev KV, Miller C, Zhang ZX, Weltzin R, Georgakopoulos K, Catalan J, Ocran S, Soike K, Ratterree M, Monath TP (2001) J Virol 75:7290–7304
Guirakhoo F, Bolin RA, Roehrig JT (1992) Virology 191:921–931
Guirakhoo F, Kitchener S, Morrison D, Forrat R, McCarthy K, Nichols R, Yoksan S, Duan X, Ermak TH, Kanesa-Thasan N, Bedford P, Lang J, Quentin-Millet MJ, Monath TP (2006) Hum Vaccin 2:60–67
Guirakhoo F, Pugachev K, Zhang Z, Myers G, Levenbook I, Draper K, Lang J, Ocran S, Mitchell F, Parsons M, Brown N, Brandler S, Fournier C, Barrere B, Rizvi F, Travassos A, Nichols R, Trent D, Monath T (2004a) J Virol 78:4761–4775
Guirakhoo F, Weltzin R, Chambers TJ, Zhang Z, Soike K, Ratterree M, Arroyo J, Georgakopoulos K, Catalan J, Monath TP (2000) J Virol 74:5477–5485
Guirakhoo F, Zhang Z, Myers G, Johnson BW, Pugachev K, Nichols R, Brown N, Levenbook I, Draper K, Cyrek S, Lang J, Fournier C, Barrere B, Delagrave S, Monath TP (2004b) J Virol 78:9998–10008
Guzman MG, Rodriguez R, Hermida L, Alvarez M, Lazo L, Mune M, Rosario D, Valdes K, Vazquez S, Martinez R, Serrano T, Paez J, Espinosa R, Pumariega T, Guillen G (2003) Am J Trop Med Hyg 69:129–134
Hermida L, Rodriguez R, Lazo L, Silva R, Zulueta A, Chinea G, Lopez C, Guzman MG, Guillen G (2004) A dengue-2 Envelope fragment inserted within the structure of the P64k meningococcal protein carrier enables a functional immune response against the virus in mice. J Virol Methods 115:41–49
Holman DH, Wang D, Raviprakash K, Raja NU, Luo M, Zhang J, Porter KR, Dong JY (2007) Clin Vaccine Immunol 14:182–189
Hotta S (1952) J Infect Dis 90:1–9
Hotta S (1969) In: Sanders M (ed) Dengue and Related Hemorrhagic Diseases. Warren H. Green Inc, St. Louis, p 166
Huang CY, Butrapet S, Pierro DJ, Chang GJ, Hunt AR, Bhamarapravati N, Gubler DJ, Kinney RM (2000) J Virol 74:3020–3028
Huang CY, Butrapet S, Tsuchiya KR, Bhamarapravati N, Gubler DJ, Kinney RM (2003) J Virol 77:11436–11447
Imoto J, Konishi E (2007) Vaccine 25:1076–1084
Innis BL, Eckels KH, Kraiselburd E, Dubois DR, Meadors GF, Gubler DJ, Burke DS, Bancroft WH (1988) J Infect Dis 158:876–880
Jaiswal S, Khanna N, Swaminathan S (2003) J Virol 77:12907–12913
Kanesa-Thasan N, Edelman R, Tacket CO, Wasserman SS, Vaughn DW, Coster TS, Kim-Ahn GJ, Dubois DR, Putnak JR, King A, Summers PL, Innis BL, Eckels KH, Hoke CH Jr (2003) Am J Trop Med Hyg 69:17–23
Kanesa-thasan N, Sun W, Kim-Ahn G, Van Albert S, Putnak JR, King A, Raengsakulsrach B, Christ-Schmidt H, Gilson K, Zahradnik JM, Vaughn DW, Innis BL, Saluzzo JF, Hoke CH Jr (2001) Vaccine 19:3179–3188
Kelly EP, Greene JJ, King AD, Innis BL (2000) Vaccine 18:2549–2559
Kitchener S, Baade L, Brennan L (2003) J Travel Med 10:50–51
Kitchener S, Nissen M, Nasveld P, Forrat R, Yoksan S, Lang J, Saluzzo JF (2006) Vaccine 24:1238–1241
Kochel T, Wu SJ, Raviprakash K, Hobart P, Hoffman S, Porter K, Hayes C (1997) Vaccine 15:547–552
Kochel TJ, Raviprakash K, Hayes CG, Watts DM, Russell KL, Gozalo AS, Phillips IA, Ewing DF, Murphy GS, Porter KR (2000) Vaccine 18:3166–3173
Konishi E, Fujii A (2002) Vaccine 20:1058–1067
Konishi E, Kosugi S, Imoto J (2006) Vaccine 24:2200–2207
Konishi E, Pincus S, Paoletti E, Shope RE, Burrage T, Mason PW (1992) Virology 188:714–720
Lai CJ, Zhao BT, Hori H, Bray M (1991) Proc Natl Acad Sci USA 88:5139–5143
Liniger M, Zuniga A, Naim HY (2007) Expert Rev Vaccines 6:255–266
McKee KT Jr, Bancroft WH, Eckels KH, Redfield RR, Summers PL, Russell PK (1987) Am J Trop Med Hyg 36:435–442
Men R, Bray M, Clark D, Chanock RM, Lai CJ (1996) J Virol 70:3930–3937
Men R, Wyatt L, Tokimatsu I, Arakaki S, Shameem G, Elkins R, Chanock R, Moss B, Lai CJ (2000) Vaccine 18:3113–3122
Men RH, Bray M, Lai CJ (1991) J Virol 65:1400–1407
Moss B (1996) Proc Natl Acad Sci USA 93:11341–11348
Porter KR, Kochel TJ, Wu SJ, Raviprakash K, Phillips I, Hayes CG (1998) Arch Virol 143:997–1003
Putnak JR, Coller BA, Voss G, Vaughn DW, Clements D, Peters I, Bignami G, Houng HS, Chen RC, Barvir DA, Seriwatana J, Cayphas S, Garcon N, Gheysen D, Kanesa-Thasan N, McDonell M, Humphreys T, Eckels KH, Prieels JP, Innis BL (2005) Vaccine 23:4442–4452
Putnak R, Barvir DA, Burrous JM, Dubois DR, D'Andrea VM, Hoke CH, Sadoff JC, Eckels KH (1996a) J Infect Dis 174:1176–1184
Putnak R, Cassidy K, Conforti N, Lee R, Sollazzo D, Truong T, Ing E, Dubois D, Sparkuhl J, Gastle W, Hoke CH Jr (1996b) Am J Trop Med Hyg 55:504–510
Putnak R, Feighny R, Burrous J, Cochran M, Hackett C, Smith G, Hoke CH Jr (1991) Am J Trop Med Hyg 45:159–167
Raja NU, Holman DH, Wang D, Raviprakash K, Juompan LY, Deitz SB, Luo M, Zhang J, Porter KR, Dong JY (2007) Am J Trop Med Hyg 76:743–751
Raviprakash K, Apt D, Brinkman A, Skinner C, Yang S, Dawes G, Ewing D, Wu SJ, Bass S, Punnonen J, Porter K (2006) Virology 353:166–173
Raviprakash K, Ewing D, Simmons M, Porter KR, Jones TR, Hayes CG, Stout R, Murphy GS (2003) Virology 315:345–352
Raviprakash K, Kochel TJ, Ewing D, Simmons M, Phillips I, Hayes CG, Porter KR (2000a) Vaccine 18:2426–2434
Raviprakash K, Marques E, Ewing D, Lu Y, Phillips I, Porter KR, Kochel TJ, August TJ, Hayes CG, Murphy GS (2001) Virology 290:74–82
Raviprakash K, Porter KR, Kochel TJ, Ewing D, Simmons M, Phillips I, Murphy GS, Weiss WR, Hayes CG (2000b) J Gen Virol 81(Pt 7):1659–1667
Raviprakash K, Wang D, Ewing D, Holman DH, Block K, Woraratanadharm J, Chen L, Hayes C, Dong JY, Porter K (2008) A Tetravalent Dengue Vaccine Based on a Complex Adenovirus Vector Provides Significant Protection in Rhesus Monkeys against All Four Serotypes of Dengue Virus. J Virol 81(14):6927–6934
Rhodes GH, Abai AM, Margalith M, Kuwahara-Rundell A, Morrow J, Parker SE, Dwarki VJ (1994) Dev Biol Stand 82:229–236
Sabchareon A, Lang J, Chanthavanich P, Yoksan S, Forrat R, Attanath P, Sirivichayakul C, Pengsaa K, Pojjaroen-Anant C, Chambonneau L, Saluzzo JF, Bhamarapravati N (2004) Pediatr Infect Dis J 23:99–109
Sabchareon A, Lang J, Chanthavanich P, Yoksan S, Forrat R, Attanath P, Sirivichayakul C, Pengsaa K, Pojjaroen-Anant C, Chokejindachai W, Jagsudee A, Saluzzo JF, Bhamarapravati N (2002) Am J Trop Med Hyg 66:264–272
Sabin A (1952) Am J Trop Med Hyg 1:30–50
Sabin AB, Schlesinger RW (1945) Science 101:640–642
Schlesinger RW, Gordon I, Frankel JW, Winter JW, Patterson PR, Dorrance WR (1956) J Immunol 77:352–364
Scott RM, Eckels KH, Bancroft WH, Summers PL, McCown JM, Anderson JH, Russell PK (1983) J Infect Dis 148:1055–1060
Simasathien S, Thomas SJ, Watanaveeradej V, Nisalak A, Barberousse C, Innis BL, Sun W, Putnak JR, Eckels KH, Hutagalung Y, Gibbons RV, Zhang C, De La Barrera R, Jarman RG, Chawachalasai W, Mammen MP Jr (2008) Am J Trop Med Hyg 78:426–433
Simmons JS, St John JH, Reynolds FHK (1931) Philipp J Sci 44:1–252
Simmons M, Nelson WM, Wu SJ, Hayes CG (1998) Am J Trop Med Hyg 58:655–662
Srivastava AK, Putnak JR, Warren RL, Hoke CH Jr (1995) Vaccine 13:1251–1258
Staropoli I, Clement JM, Frenkiel MP, Hofnung M, Deubel V (1996) J Virol Methods 56:179–189
Staropoli I, Frenkiel MP, Megret F, Deubel V (1997) Vaccine 15:1946–1954
Sugrue RJ, Fu J, Howe J, Chan YC (1997) J Gen Virol 78:1861–1866
Sun W, Edelman R, Kanesa-Thasan N, Eckels KH, Putnak JR, King AD, Houng HS, Tang D, Scherer JM, Hoke CH Jr, Innis BL (2003) Am J Trop Med Hyg 69:24–31
Vaughn DW, Hoke CH Jr, Yoksan S, LaChance R, Innis BL, Rice RM, Bhamarapravati N (1996) Vaccine 14:329–336
Velzing J, Groen J, Drouet MT, van Amerongen G, Copra C, Osterhaus AD, Deubel V (1999) Vaccine 17:1312–1320
Whalen RG (1996) Emerg Infect Dis 2:168–175
Whitehead SS, Blaney JE, Durbin AP, Murphy BR (2007) Nat Rev Microbiol 5:518–528
Whitehead SS, Falgout B, Hanley KA, Blaney JE Jr, Markoff L, Murphy BR (2003a) J Virol 77:1653–1657
Whitehead SS, Hanley KA, Blaney JE Jr, Gilmore LE, Elkins WR, Murphy BR (2003b) Vaccine 21:4307–4316
Wisseman CL Jr, Sweet BH, Rosenzweig EC, Eylar OR (1963) Am J Trop Med Hyg 12:620–623
Wu SF, Liao CL, Lin YL, Yeh CT, Chen LK, Huang YF, Chou HY, Huang JL, Shaio MF, Sytwu HK (2003) Vaccine 21:3919–3929
Yang ZY, Wyatt LS, Kong WP, Moodie Z, Moss B, Nabel GJ (2003) J Virol 77:799–803
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Durbin, A.P., Whitehead, S.S. (2010). Dengue Vaccine Candidates in Development. In: Rothman, A. (eds) Dengue Virus. Current Topics in Microbiology and Immunology, vol 338. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-02215-9_10
Download citation
DOI: https://doi.org/10.1007/978-3-642-02215-9_10
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-02214-2
Online ISBN: 978-3-642-02215-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)